How to Show Value and ROI as a Digital Mental Health Business, with Val Hoffman
Digital mental health companies face increasing pressure to demonstrate clinical and economic value to payers, providers, and partners.
In this Hemingway session, Val Hoffman will share practical frameworks for evidence generation that balance scientific rigour with realistic startup constraints. Drawing from her work with dozens of companies, she'll outline what data to collect from day one, how to design studies that satisfy multiple stakeholders, and strategies for translating research findings into compelling ROI models.
What you will learn:
Which data to collect from launch to build credible evidence without derailing product development
How to design pragmatic studies that satisfy payers, providers, and peer reviewers simultaneously
Building ROI models that will actually help you win and retain deals
About Val Hoffman:
Val Hoffman is a psychiatric epidemiologist who has spent nearly 25 years at the intersection of mental health research and digital innovation. Her career spans academic research, industry leadership, and digital health product development, including roles as Chief Research Officer at Meru Health and VP of Intervention Science at Woebot Health.
As Founder and CEO of Pogo Research, Val partners with digital mental health companies to transform research into business value. She helps startups and scale-ups navigate evidence generation, cost-modeling, and value demonstration - from developing research strategies and securing NIH SBIR funding to creating ROI models and translating data insights into product improvements that enhance patient care.
Val's work bridges the gap between rigorous science and commercial viability, making her a trusted advisor to founders building the next generation of mental health interventions.
__
Only Hemingway Community members will be approved to join the event. Learn more about joining the Hemingway Community here > https://www.thehemingwayreport.com/community